Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1781 37
1782 18
1783 22
1784 27
1785 43
1786 60
1787 43
1788 33
1789 32
1790 44
1791 19
1792 33
1793 17
1794 18
1795 13
1796 15
1797 59
1798 15
1799 291
1800 377
1801 360
1802 283
1803 269
1804 289
1805 314
1806 282
1807 295
1808 289
1809 265
1810 267
1811 322
1812 238
1813 265
1814 285
1815 222
1816 315
1817 288
1818 303
1819 225
1820 213
1821 270
1822 247
1823 291
1824 269
1825 262
1826 385
1827 326
1828 467
1829 645
1830 569
1831 627
1832 313
1833 293
1834 287
1835 305
1836 271
1837 350
1838 484
1839 546
1840 695
1841 1155
1842 1488
1843 1118
1844 1248
1845 1278
1846 1406
1847 1367
1848 1204
1849 1208
1850 1126
1851 1228
1852 1310
1853 1559
1854 1306
1855 1587
1856 1587
1857 1488
1858 1542
1859 1562
1860 1632
1861 1275
1862 1112
1863 996
1864 1139
1865 1151
1866 1477
1867 1723
1868 1813
1869 1909
1870 1810
1871 2238
1872 2242
1873 2313
1874 2510
1875 2403
1876 2095
1877 2180
1878 2454
1879 2399
1880 2647
1881 3150
1882 2745
1883 3129
1884 3052
1885 3339
1886 3293
1887 3965
1888 4003
1889 4196
1890 4025
1891 3607
1892 4081
1893 4371
1894 3801
1895 4129
1896 4413
1897 4689
1898 4632
1899 4169
1900 3787
1901 3887
1902 3968
1903 3910
1904 4060
1905 4067
1906 3873
1907 4323
1908 4461
1909 4688
1910 4799
1911 5007
1912 4908
1913 5108
1914 5135
1915 4641
1916 4543
1917 4282
1918 4568
1919 4620
1920 4960
1921 4628
1922 4123
1923 4432
1924 4851
1925 4991
1926 5342
1927 5887
1928 5479
1929 5741
1930 5630
1931 5496
1932 5548
1933 5610
1934 5508
1935 5661
1936 5384
1937 5308
1938 5765
1939 5541
1940 4998
1941 4838
1942 4775
1943 4517
1944 4746
1945 20423
1946 53740
1947 64968
1948 70728
1949 62806
1950 85750
1951 103810
1952 108147
1953 108914
1954 105913
1955 108541
1956 107005
1957 111515
1958 109459
1959 109988
1960 112210
1961 120167
1962 125670
1963 141520
1964 162087
1965 176652
1966 179782
1967 191558
1968 207870
1969 215094
1970 218989
1971 222940
1972 227553
1973 230697
1974 234588
1975 248367
1976 251842
1977 254358
1978 263186
1979 271235
1980 272031
1981 276299
1982 288281
1983 300841
1984 309098
1985 325908
1986 338926
1987 355407
1988 372407
1989 387175
1990 393529
1991 392539
1992 394769
1993 403821
1994 414930
1995 424291
1996 434808
1997 432646
1998 450482
1999 468539
2000 506198
2001 518994
2002 537141
2003 565541
2004 608864
2005 669032
2006 717910
2007 755467
2008 804374
2009 844843
2010 908485
2011 983815
2012 1049022
2013 1102602
2014 1157133
2015 1199041
2016 1227930
2017 1249398
2018 1295098
2019 1357403
2020 1561918
2021 1705461
2022 1702858
2023 1616173
2024 1660263
2025 1789390
2026 872103
2027 41
2028 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

39,049,361 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Radiation Induced Rectum Toxicity"
Page 1
[Prostate cancer brachytherapy].
Pommier P, Guérif S, Peiffert D, Créhange G, Hannoun-Lévi JM, de Crevoisier R. Pommier P, et al. Cancer Radiother. 2016 Sep;20 Suppl:S210-5. doi: 10.1016/j.canrad.2016.07.038. Epub 2016 Aug 11. Cancer Radiother. 2016. PMID: 27523412 French.
Prostate brachytherapy techniques are described, concerning both Iodine 125 high dose rate brachytherapy. The following parts are presented: brachytherapy indications, technical description, immediate postoperative management and post-treatment evaluation, and 4 to 6 weeks
Prostate brachytherapy techniques are described, concerning both Iodine 125 high dose rate brachytherapy. The following parts are pre
Predicting toxicity in radiotherapy for prostate cancer.
Landoni V, Fiorino C, Cozzarini C, Sanguineti G, Valdagni R, Rancati T. Landoni V, et al. Phys Med. 2016 Mar;32(3):521-32. doi: 10.1016/j.ejmp.2016.03.003. Epub 2016 Apr 8. Phys Med. 2016. PMID: 27068274 Review.
This comprehensive review addresses most organs at risk involved in planning optimization for prostate cancer. It can be considered an update of a previous educational review that was published in 2009 (Fiorino et al., 2009). ...A focus was on external bea
This comprehensive review addresses most organs at risk involved in planning optimization for prostate cancer. It can be consi …
Radiation dose-volume effects in radiation-induced rectal injury.
Michalski JM, Gay H, Jackson A, Tucker SL, Deasy JO. Michalski JM, et al. Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3 Suppl):S123-9. doi: 10.1016/j.ijrobp.2009.03.078. Int J Radiat Oncol Biol Phys. 2010. PMID: 20171506 Free PMC article. Review.
Parameters for the Lyman-Kutcher-Burman normal tissue complication probability model from four clinical series are remarkably consistent, suggesting that high doses are predominant in determining the risk of toxicity. …
Parameters for the Lyman-Kutcher-Burman normal tissue complication probability model
Radiotherapy of Cervical Cancer.
Vordermark D. Vordermark D. Oncol Res Treat. 2016;39(9):516-20. doi: 10.1159/000448902. Epub 2016 Aug 18. Oncol Res Treat. 2016. PMID: 27614991 Review.
Curative-intent radical radiotherapy of cervical cancer consists of external-beam radiotherapy, brachytherapy, and concomitant chemotherapy with cisplatin. For each element, new developments aim to improve tumor control rates or treatment tolerance. Intens
Curative-intent radical radiotherapy of cervical cancer consists of external-beam radiotherapy, brachytherapy, and conc …
Serum metabolic traits reveal therapeutic toxicities and responses of neoadjuvant chemoradiotherapy in patients with rectal cancer.
Wang H, Jia H, Gao Y, Zhang H, Fan J, Zhang L, Ren F, Yin Y, Cai Y, Zhu J, Zhu ZJ. Wang H, et al. Nat Commun. 2022 Dec 17;13(1):7802. doi: 10.1038/s41467-022-35511-y. Nat Commun. 2022. PMID: 36528604 Free PMC article. Clinical Trial.
Therapeutic efficacy of nCRT is significantly affected by treatment-induced diarrhea and hematologic toxicities. Metabolic alternations in cancer therapy are key determinants to therapeutic toxicities and responses, but exploration in large-scale clinical stu …
Therapeutic efficacy of nCRT is significantly affected by treatment-induced diarrhea and hematologic toxicities. Metabolic alt …
MR-guided radiotherapy for prostate cancer: an inevitable transition?
Stando R, Chmielewski G. Stando R, et al. Curr Opin Urol. 2025 Sep 1;35(5):562-567. doi: 10.1097/MOU.0000000000001315. Epub 2025 Jul 4. Curr Opin Urol. 2025. PMID: 40620056 Review.
PURPOSE OF REVIEW: The rising global incidence of prostate cancer has intensified both clinical and economic pressures to optimize radiotherapy (RT) delivery. ...SUMMARY: Based on available, preliminary evidence, MRgRT and adaptive SBRT are associated with a promisi …
PURPOSE OF REVIEW: The rising global incidence of prostate cancer has intensified both clinical and economic pressures to opti …
Rectal radiation dose-reduction techniques in prostate cancer: a focus on the rectal spacer.
Leiker AJ, Desai NB, Folkert MR. Leiker AJ, et al. Future Oncol. 2018 Nov;14(26):2773-2788. doi: 10.2217/fon-2018-0286. Epub 2018 Jun 25. Future Oncol. 2018. PMID: 29939069 Review.
Prostate cancer is the most common cancer in men. External beam radiotherapy by a variety of methods is a standard treatment option with excellent disease control. ...A number of techniques have emerged that allow for high-radiation do
Prostate cancer is the most common cancer in men. External beam radiotherapy by a variety of methods is a
Reducing rectal injury during external beam radiotherapy for prostate cancer.
Valdagni R, Rancati T. Valdagni R, et al. Nat Rev Urol. 2013 Jun;10(6):345-57. doi: 10.1038/nrurol.2013.96. Epub 2013 May 14. Nat Rev Urol. 2013. PMID: 23670182 Review.
Rectal bleeding and faecal incontinence are serious injuries that men with prostate cancer who receive radiotherapy can experience. Although technical advances--including the use of intensity-modulated radiotherapy coupled with image-guided radiotherap …
Rectal bleeding and faecal incontinence are serious injuries that men with prostate cancer who receive radiotherapy can experi …
Radiotherapy Boost for the Dominant Intraprostatic Cancer Lesion-A Systematic Review and Meta-Analysis.
von Eyben FE, Kiljunen T, Kangasmaki A, Kairemo K, von Eyben R, Joensuu T. von Eyben FE, et al. Clin Genitourin Cancer. 2016 Jun;14(3):189-97. doi: 10.1016/j.clgc.2015.12.005. Epub 2015 Dec 17. Clin Genitourin Cancer. 2016. PMID: 26768965
External beam radiotherapy (EBRT) for prostate cancer can be performed with a high dose of 86 Gy; however, one-tenth or more of the patients will develop recurrence. Prostate cancer is mainly multifocal, but a dominant intraprostat
External beam radiotherapy (EBRT) for prostate cancer can be performed with a high dose of 86 Gy; however
Late gastrointestinal tissue effects after hypofractionated radiation therapy of the pancreas.
Elhammali A, Patel M, Weinberg B, Verma V, Liu J, Olsen JR, Gay HA. Elhammali A, et al. Radiat Oncol. 2015 Sep 4;10:186. doi: 10.1186/s13014-015-0489-2. Radiat Oncol. 2015. PMID: 26337917 Free PMC article. Review.
BACKGROUND: To consolidate literature reports of serious late gastrointestinal toxicities after hypofractionated radiation treatment of pancreatic cancer and attempt to derive normal tissue complication probability (NTCP) parameters using the Lyman- …
BACKGROUND: To consolidate literature reports of serious late gastrointestinal toxicities after hypofractionated radiation tre …
39,049,361 results
You have reached the last available page of results. Please see the User Guide for more information.